Table 2.
Cases (n=12) | Controls (n=26) | p-value | |
---|---|---|---|
Gender | 0.90 | ||
Male | 9 (75%) | 19 (73%) | |
Female | 3 (25%) | 7 (27%) | |
Age at XRT | |||
Mean | 52.3 (0%) | 57 (0%) | |
Median | 53 (0%) | 55 (0%) | |
Range | 32–53 | 33–55 | |
T Stage | 0.001* | ||
T1 | 0 (0%) | 13 (50%) | |
T2 | 5 (42%) | 9 (35%) | |
T3 | 6 (50%) | 4 (15%) | |
T4 | 1 (8%) | 0 (0%) | |
N Stage | 0.11 | ||
N0 | 1 (8%) | 0 (0%) | |
N1 | 1 (8%) | 0 (0%) | |
N2A | 1 (8%) | 0 (0%) | |
N2B | 6 (50%) | 17 (65%) | |
N2C | 2 (17%) | 8 (31%) | |
N3 | 1 (8%) | 1 (4%) | |
Subsite | 0.16 | ||
Base of Tongue | 5 (42%) | 18 (69%) | |
Tonsil | 7 (58%) | 8 (31%) | |
Cigarettes at Diagnosis | 0.91 | ||
Never (<100 cig/lifetime) | 6 (50%) | 14 (54%) | |
Former (quit > 1 year) | 4 (33%) | 9 (34%) | |
Current | 2 (17%) | 3 (12%) | |
Race | 0.39 | ||
White | 10 (83%) | 24 (92%) | |
Black | 1 (8%) | 0 (0%) | |
Latin American | 1 (8%) | 1 (4%) | |
Asian | 0 (0%) | 1 (4%) | |
Accelerated Fractionation | 0.06 | ||
Single | 4 (33%) | 17 (65%) | |
Accelerated | 8 (67%) | 9 (35%) | |
Concurrent | 0.07 | ||
No | 5 (42%) | 19 (73%) | |
Yes | 7 (58%) | 7 (27%) |